These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
1. DGX reported Q1 earnings of $2.21 per share, beating estimates. 2. Quarterly sales reached $2.65 billion, exceeding expectations. 3. Revenue growth was 12%, with nearly 2.5% organic growth. 4. Guidance for 2025 revenue reaffirmed at $10.70-$10.85 billion. 5. Analysts raised price targets but overall shares slightly declined.